Area of research
Clinical Psychology · Neurology
Research interest
Research focused on Treatment-resistant depression and Depression (economics), with related work in Tolerability, Neuropsychology, Cognition. Notable publications include 'Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression', 'Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial', and 'HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition'.
Increased cortical thickness and decreased brain age among special operations veterans with blast TBI after a magnesium-ibogaine protocol
Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in Special Operations Veterans with traumatic brain injuries
Magnesium–ibogaine therapy in veterans with traumatic brain injuries
Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine
0665 Ibogaine treatment in combat Veterans significantly improves sleep, beyond alleviating Posttraumatic Stress Disorder symptoms
Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
Multiculturalism: A Challenge for Cognitive Screeners in Parkinson's Disease
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT-TRD) induces rapid remission from treatment-resistant depression in a double-blinded, randomized, and controlled trial.
HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)